z-logo
open-access-imgOpen Access
Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480
Author(s) -
Ye Qi,
Li Su,
Dagui Chen,
Wenyi Zheng,
Ye Liu
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000482025
Subject(s) - colorectal cancer , oxaliplatin , cancer research , epithelial–mesenchymal transition , cell growth , medicine , chemotherapy , cancer , signal transduction , transfection , cell culture , oncology , biology , metastasis , microbiology and biotechnology , genetics
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Although chemotherapy is the primary means in colorectal cancer treatment, it is burdenerd by adverse drug effects. Drug-resistance is one of the most important challenges for chemotherapy and epithelial-mesenchymal transition (EMT) plays critical role in the development of drug resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here